PAXMEDICA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.294 USD | -5.77% |
|
-13.53% | -61.16% |
| May. 13 | PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 06 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index | CI |
Evolution of the average Target Price on PaxMedica, Inc.
Price target over the last 5 years
History of analyst recommendation changes
4c5cc80e6bb2be225b3.0ty3AycXjTYkZNLU2chhAdHH2xcEBw5LgA3XP1Mydow.5-XiW1ZC5V9lDbfjqZI1SOiDrFpIM1l71UCycH5QBvzli_FCVF7sYnYSlw~98ea1d472dac2cc1b62731ca22a8e8cd
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.312
USD
Average target price
3
USD
Spread / Average Target
+861.54%
High Price Target
3
USD
Spread / Highest target
+861.54%
Low Price Target
3
USD
Spread / Lowest Target
+861.54%
Consensus detail
Consensus revision (last 18 months)
Analysts covering PaxMedica, Inc.
| HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- PXMD Stock
- Consensus PaxMedica, Inc.
